Geron | GERN - Equity Capital And Reserves

Stock Price
1.29
Daily Change
-0.11 -7.86%
Monthly
-23.67%
Yearly
1.57%
Q2 Forecast
1.26

Geron reported $229.11M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Amgen USD 9.19B 532M Mar/2026
Bio Techne USD 2.09B 74.32M Mar/2026
Cassava Sciences USD 68.14M 6.26M Mar/2026
Cytokinetics USD -826.57M 166.94M Mar/2026
Esperion Therapeutics USD -307.93M 5.97M Mar/2026
Exelixis USD 1.94B 225.57M Mar/2026
Genmab DKK 5.85B 96M Dec/2025
Geron USD 229.11M 3.24M Mar/2026
Gilead Sciences USD 23.52B 897M Mar/2026
Incyte USD 5.62B 455.37M Mar/2026
MacroGenics USD 21.2M 34.39M Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Novavax USD -144.76M 17.01M Mar/2026